STAT April 29, 2024
WASHINGTON — A federal judge in New Jersey on Monday dealt a blow to two drugmakers challenging the Biden administration’s new Medicare drug price negotiation authority, ruling that the program is constitutional.
The challenge, brought by Bristol Myers Squibb and Johnson & Johnson, argued that the drug price program created in the Inflation Reduction Act is an...